Orchestra BioMed Holdings, Inc. OBIO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -56.95M | -59.03M | -54.64M | -52.70M | -75.10M |
| Total Depreciation and Amortization | 369.00K | 349.00K | 334.00K | 327.00K | 329.00K |
| Total Amortization of Deferred Charges | 258.00K | 252.00K | 233.00K | 215.00K | 182.00K |
| Total Other Non-Cash Items | 8.21M | 13.40M | 12.60M | 13.57M | 13.81M |
| Change in Net Operating Assets | -15.20M | -13.29M | -13.05M | -10.37M | 546.00K |
| Cash from Operations | -63.31M | -58.32M | -54.52M | -48.96M | -60.23M |
| Capital Expenditure | -869.00K | -781.00K | -561.00K | -489.00K | -562.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -602.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.87M | -68.51M | -29.06M | -26.45M | -11.82M |
| Cash from Investing | -9.74M | -69.29M | -29.62M | -26.94M | -12.98M |
| Total Debt Issued | 35.00M | 55.00M | 20.00M | 20.00M | 35.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.46M | 65.21M | 65.20M | 59.41M | 57.92M |
| Repurchase of Common Stock | -1.25M | -1.35M | -1.52M | -1.55M | -1.63M |
| Issuance of Preferred Stock | 12.56M | 12.56M | 12.56M | 12.56M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -972.00K | -2.09M | -2.09M | -2.09M | -1.67M |
| Cash from Financing | 58.80M | 129.33M | 94.16M | 88.33M | 89.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.25M | 1.72M | 10.02M | 12.43M | 16.41M |